Condition

Heart Failure With Preserved Ejection Fraction

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 238 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials238
Recruiting46
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection FractionNCT07401771 · 2026-11-01
RECRUITING
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionNCT07123779 · 2026-09-01
RECRUITING
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)NCT07795814 · 2026-08-25
RECRUITING
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart DiseaseNCT07214376 · 2026-08-21
RECRUITING
Incretin Therapies in Obesity-related HFpEFNCT07554638 · 2026-08-07
RECRUITING
EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)NCT07202000 · 2026-06-03
RECRUITING
BOOST: Blended Onsite and Offsite Structured Exercise Training and CoachingNCT07413198 · 2026-05-05
RECRUITING
A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection FractionNCT07269717 · 2026-03-30
RECRUITING
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart FailureNCT07083011 · 2025-11-01
RECRUITING
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMDNCT07093528 · 2025-10-16
RECRUITING
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate ControlNCT06833138 · 2025-09-10
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25
RECRUITING
SHort Of Pace - Heart Failure (SHOP-HF)NCT06992089 · 2025-06-17
RECRUITING
The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)NCT06702501 · 2025-02-17
RECRUITING
Myocardial Mechanisms in Heart Failure With Preserved Ejection FractionNCT06517186 · 2024-11-08
RECRUITING
Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection FractionNCT06652763 · 2024-10-10
RECRUITING
Leg Heat Therapy in Heart Failure With Preserved Ejection FractionNCT06388226 · 2024-08-15
RECRUITING
Managing Congestion in Heart Failure: A Mechanistic Study in Patients With HFpEFNCT06977477 · 2024-06-18
RECRUITING
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)NCT06337812 · 2024-04-01
RECRUITING
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal DiseaseNCT06249945 · 2024-03-05
RECRUITING
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEFNCT06208007 · 2024-02-23
RECRUITING
A Preliminary Study for INFORMEDNCT05585125 · 2024-02-07
RECRUITING
Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection FractionNCT06196086 · 2023-12-20
RECRUITING
Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDicationNCT06278844 · 2023-12-12
RECRUITING
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection FractionNCT06061549 · 2023-08-24
RECRUITING
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus ParticipantsNCT05838287 · 2023-07-10
RECRUITING
Targeting Breathing Limitations to Improve Functional Outcomes in HFpEFNCT05723679 · 2023-07-01
RECRUITING
PBMC as Biomarkers of Diabetic CardiomyopathyNCT05651919 · 2023-05-23
RECRUITING
Ketogenic Diet vs Mixed Diet in Patients With Heart FailureNCT06081543 · 2023-05-19
RECRUITING
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionNCT06409585 · 2023-05-01
RECRUITING
Provocative Tests for HFpEFNCT06309550 · 2023-03-10
RECRUITING
CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection FractionNCT05508256 · 2023-03-01
RECRUITING
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment TargetsNCT05873634 · 2023-03-01
RECRUITING
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection FractionNCT05525663 · 2023-02-16
RECRUITING
Exercise Lower-body Negative Pressure in Heart Failure With Preserved Ejection FractionNCT05582044 · 2023-01-25
RECRUITING
The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection FractionNCT05878912 · 2023-01-20
RECRUITING
Assessment of CCM in HF With Higher Ejection FractionNCT05064709 · 2022-02-03
RECRUITING
SGLT2i and KNO3 in HFpEF - The SAK HFpEF TrialNCT05138575 · 2022-01-24
RECRUITING
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection FractionNCT05174351 · 2021-12-20
RECRUITING
Matching Perfusion and Metabolic Activity in HFpEFNCT04913805 · 2021-10-11
RECRUITING
Novel Approaches for Improving Vascular Function in Veterans With HFpEFNCT06312748 · 2021-05-19
RECRUITING
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research PlanNCT05057806 · 2021-01-13
RECRUITING
The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on ExertionNCT05490901 · 2020-03-17
RECRUITING
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health SystemNCT04237701 · 2019-10-01
RECRUITING
Purinergic Signaling and the Postmenopausal HeartNCT06015776 · 2019-07-01
RECRUITING
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection FractionNCT02901184 · 2017-11-23
RECRUITING
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF RegistryNCT07787936 · 2027-01-01
NOT_YET_RECRUITING
Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection FractionNCT07331220 · 2026-12-30
NOT_YET_RECRUITING
CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)NCT07254455 · 2026-10-01
NOT_YET_RECRUITING
Finerenone and Cardiac Remodeling in HFpEFNCT07830940 · 2026-09-20
NOT_YET_RECRUITING
Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection FractionNCT06536309 · 2026-08-27
WITHDRAWN
IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron DeficiencyNCT07686692 · 2026-08-01
NOT_YET_RECRUITING
AI-based Echocardiographic Quantification in Heart FailureNCT07010952 · 2025-07-01
NOT_YET_RECRUITING
Transitions of Care Clinic (TOCC)NCT06937827 · 2025-06-26
TERMINATED
Staging Heart Failure With Preserved Ejection FractionNCT06931015 · 2025-04-20
NOT_YET_RECRUITING
Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection FractionNCT06581159 · 2025-01-23
TERMINATED
Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot StudyNCT06567925 · 2025-01-21
COMPLETED
Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims DataNCT07599293 · 2024-10-13
COMPLETED
Chemoreflex Sensitivity in HFpEFNCT06309537 · 2024-10-01
NOT_YET_RECRUITING
Fast Induced Remodeling in Heart Failure With Preserved Ejection FractionNCT05839730 · 2024-09-11
ACTIVE_NOT_RECRUITING

Common interventions

Trial status mix

COMPLETED84
UNKNOWN55
RECRUITING46
TERMINATED17
ACTIVE_NOT_RECRUITING14
NOT_YET_RECRUITING11
WITHDRAWN10
ENROLLING_BY_INVITATION1

Phase mix

NA68
PHASE238
PHASE426
PHASE316
PHASE19
EARLY_PHASE14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.